Iovance Biotherapeutics, Inc.
IOVA
Rang în acțiuni
#2760
Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical... Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recurrent, metastatic, or persistent. Additionally, investigational product LN-145 is undergoing evaluation in trial C-145-03 for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. maintains strategic alliances and licensing arrangements with several distinguished entities, including H. Lee Moffitt Cancer Center, M.D. Anderson Cancer Center, Ohio State University, the Centre hospitalier de l'Université de Montreal, Cellectis S.A., and Novartis Pharma AG. Established in 2007, the company was previously known as Lion Biotechnologies, Inc. It adopted its current name, Iovance Biotherapeutics, Inc., in June 2017. Its corporate offices are located in San Carlos, California.
Preț acțiune
$14.72
Ultima sincronizare: 2026-10-21
Capitalizare de piață
$6.67B
Schimbare (1 zi)
-0.98%
Schimbare (1 an)
584.42%
Țară
US
Tranzacționează Iovance Biotherapeutics, Inc. (IOVA)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Iovance Biotherapeutics, Inc. (IOVA)
Cel mai mare preț de închidere: $14.14 pe 2026-10-01
Cel mai mic preț de închidere: $103.55 pe 2010-10-01
Cel mai mic preț de închidere: $103.55 pe 2010-10-01
Istoric al prețului acțiunii pentru Iovance Biotherapeutics, Inc. din 2010 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | 100.26% |
| 2025 | -69.46% |
| 2024 | 9.49% |
| 2023 | 11.39% |
| 2022 | -64.95% |
| 2021 | -60.13% |
| 2020 | 75.74% |
| 2019 | 190.57% |
| 2018 | 7.35% |
| 2017 | 24.29% |
| 2016 | -11.09% |
| 2015 | 11.54% |
| 2014 | -28.26% |
| 2013 | -59.07% |
| 2012 | -76.79% |
| 2011 | -13.84% |
| 2010 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $528.84 | 24.01% |
US
|
|
| $237.25 | 783.61% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $891.40 | 9.49% |
NL
|
|
| $289.06 | 1.56% |
BE
|
